Latest filing published 12 May 2026 for Neurizon Therapeutics Limited.
Dr. Michael Thurn: trading record in brief
All filings by Dr. Michael Thurn on record concern Neurizon Therapeutics Limited, in the capacity of board member. Between 30 April 2026 and 12 May 2026, the trades on record add up to 2 filings.
Every open-market trade on record is a sale: 1 sale. The totals exclude 1 filing filed without an amount.
On 12 May 2026 came the latest disclosure, a transaction in Neurizon Therapeutics Limited. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from ASX. Past trades are no guide to future returns.
Companies and markets linked to Dr. Michael Thurn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ShareASXISIN AU0000357261ASX:2924-03089281-6A1325154
- 500,000 sharesShareASXASX:2924-03086191-6A1323896
2 of 2 declarations